Didier Hirsch
Director · SOPHiA GENETICS SA
- 2024
- Jun 22, 2026
- 3
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Didier Hirsch files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Jeffrey Niew - $19.64M in KN purchases and sales in the last 12 months
- John S. Anderson - $3.12M in KN purchases and sales in the last 12 months
- Jurgi Camblong - $2.65M in SOPH purchases and sales in the last 12 months
- Daniel J. Giesecke - $1.19M in KN purchases and sales in the last 12 months
- Keith Barnes - $1.11M in KN purchases and sales in the last 12 months
- Zhenyu Xu - $761K in SOPH purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Didier Hirsch?
Didier Hirsch is a corporate insider, tracked as Director of SOPHiA GENETICS SA (SOPH). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Didier Hirsch last file a Form 4?
The most recent primary Form 4 on record is dated 22 June 2026, one of 3 filings going back to 2024.
Has Didier Hirsch been buying or selling stock?
Recorded transactions: 1 open-market purchase ($40K) and 0 open-market sales across all tracked filings.
